AIM ImmunoTech Inc.(AIM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AIM AIM ImmunoTech Inc.

盘后交易 03-02 16:32:44 EST

0.7725

-0.1351

-14.89%

盘后0.8000

+0.0275+3.56%

16:27 EST

最高0.9473	最低0.7725	成交量37.45万
今开0.9300	昨收0.9076	日振幅19.26%
总市值253.10万	流通市值239.11万	总股本327.64万
成交额31.44万	换手率12.10%	流通股本309.53万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AIM","market":"US","secType":"STK","nameCN":"AIM ImmunoTech Inc.","latestPrice":0.7725,"timestamp":1772485200000,"preClose":0.907599,"halted":0,"volume":374525,"hourTrading":{"tag":"盘后","latestPrice":0.8,"preClose":0.7725,"latestTime":"16:27 EST","volume":2497,"amount":1946.80040775,"timestamp":1772486846980,"change":0.0275,"changeRate":0.035599,"amplitude":0.035599},"delay":0,"changeRate":-0.14885318295855338,"floatShares":3095299,"shares":3276400,"eps":-19.818182,"marketStatus":"盘后交易","change":-0.135099,"latestTime":"03-02 16:32:44 EST","open":0.93,"high":0.9473,"low":0.7725,"amount":314448.208781,"amplitude":0.192596,"askPrice":0.8,"askSize":100,"bidPrice":0.7778,"bidSize":15,"shortable":0,"etf":0,"ttmEps":-19.818182,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1772499600000},"marketStatusCode":4,"adr":0,"exchange":"AMEX","adjPreClose":0.907599,"preHourTrading":{"tag":"盘前","latestPrice":0.92,"preClose":0.9075,"latestTime":"09:21 EST","volume":3938,"amount":3596.8971346,"timestamp":1772461319560,"change":0.0125,"changeRate":0.013774,"amplitude":0.126501},"postHourTrading":{"tag":"盘后","latestPrice":0.8,"preClose":0.7725,"latestTime":"16:27 EST","volume":2497,"amount":1946.80040775,"timestamp":1772486846980,"change":0.0275,"changeRate":0.035599,"amplitude":0.035599},"volumeRatio":1.271203},"requestUrl":"/m/hq/s/AIM","defaultTab":"news","newsList":[{"id":"1111519376","title":"AIM ImmunoTech就晚期胰腺癌疗法Ampligen拟定三期临床试验规划签署协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1111519376","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111519376?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:01","pubTimestamp":1772460104,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech Inc. 已签署一项协议，旨在规划其核心候选药物Ampligen用于治疗晚期胰腺癌的一项拟议三期临床试验。此举标志着该公司在推进该免疫疗法针对这一难治癌症的临床开发进程中迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIM","BK4139","BK4557"],"gpt_icon":0},{"id":"1147759942","title":"AIM ImmunoTech宣布将先前公布的配股认购期延长至2026年3月3日","url":"https://stock-news.laohu8.com/highlight/detail?id=1147759942","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147759942?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:07","pubTimestamp":1772028423,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech Inc. 近日发布公告，决定将其先前已宣布的配股计划中的股东认购权利行使期限进行延长。新的最终截止日期现已确定为2026年3月3日。此举为公司股东提供了更为充裕的时间来考虑并行使其在此次融资活动中的相关权利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIM","BK4139","BK4557"],"gpt_icon":0},{"id":"1142732216","title":"AIM ImmunoTech公布Ampligen与阿斯利康Durvalumab联合治疗转移性胰腺癌的二期试验规划里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1142732216","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142732216?lang=zh_cn&edition=full","pubTime":"2026-02-23 21:58","pubTimestamp":1771855089,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech Inc. 近日披露了其正在进行的二期临床试验的关键规划节点，该试验旨在评估其核心药物Ampligen与阿斯利康（AstraZeneca）的Durvalumab联合用于治疗转移性胰腺癌的疗效。公司明确了试验推进过程中的若干重要阶段，标志着该联合疗法研发进程的稳步推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIM","BK4139","BK4557"],"gpt_icon":0},{"id":"1110033028","title":"AIM ImmunoTech公布Ampligen®联合阿斯利康Imfinzi®治疗胰腺癌的II期研究年终中期积极临床进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1110033028","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110033028?lang=zh_cn&edition=full","pubTime":"2026-02-05 21:45","pubTimestamp":1770299127,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech Inc. 宣布，其评估Ampligen®联合阿斯利康Imfinzi®用于治疗胰腺癌的II期研究，在年终时取得了积极的中期临床进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIM","BK4139","BK4557"],"gpt_icon":0},{"id":"2607645065","title":"Aim Immunotech Inc.盘中异动 股价大跌5.74%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607645065","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607645065?lang=zh_cn&edition=full","pubTime":"2026-01-30 02:57","pubTimestamp":1769713071,"startTime":"0","endTime":"0","summary":"北京时间2026年01月30日02时57分，Aim Immunotech Inc.股票出现波动，股价大幅跳水5.74%。截至发稿，该股报1.15美元/股，成交量6.1535万股，换手率1.92%，振幅4.92%。Aim Immunotech Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Aim Immunotech Inc.公司简介：AIM ImmunoTech Inc 是一家免疫制药公司，专注于研究和开发用于治疗多种癌症、病毒性疾病和免疫缺陷疾病的疗法，以及治疗目前疗法不足或未得到满足的癌症。Ampligen 已获准在阿根廷共和国进行商业销售，用于治疗严重的慢性疲劳综合症 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130025751953efc34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130025751953efc34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AIM","BK4557","BK4139"],"gpt_icon":0},{"id":"2603568688","title":"Aim Immunotech Inc.盘中异动 快速下挫6.20%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603568688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603568688?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:39","pubTimestamp":1768228770,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时39分，Aim Immunotech Inc.股票出现波动，股价急速下跌6.20%。截至发稿，该股报1.21美元/股，成交量1.6471万股，换手率0.56%，振幅4.66%。Aim Immunotech Inc.股票所在的生物技术行业中，整体跌幅为1.24%。Aim Immunotech Inc.公司简介：AIM ImmunoTech Inc 是一家免疫制药公司，专注于研究和开发用于治疗多种癌症、病毒性疾病和免疫缺陷疾病的疗法，以及治疗目前疗法不足或未得到满足的癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011222393197a1768a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011222393197a1768a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4139","AIM"],"gpt_icon":0},{"id":"2590632000","title":"里程碑！FDA首次批准AI工具助力新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2590632000","media":"Med新声","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590632000?lang=zh_cn&edition=full","pubTime":"2025-12-09 14:16","pubTimestamp":1765260981,"startTime":"0","endTime":"0","summary":"12月8日路透社消息，FDA宣布，已正式批准首款人工智能工具用于药物临床试验中重度脂肪肝疾病的评估工作。据FDA介绍，目前MASH药物临床试验中，肝活检样本需经多名专家独立评审，不仅流程繁琐缓慢，且评审结果易出现不一致性。此次FDA的资格认定，基于多项研究证实：AIM-NASH辅助下的评估结果，与单个专家的独立评审水平相当，其准确性和可靠性得到充分验证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209145228a72cb8ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209145228a72cb8ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","AIM","BK4139"],"gpt_icon":1},{"id":"1110764691","title":"AIM ImmunoTech发布2025年第三季度财务业绩，并强调在胰腺癌临床项目中的持续进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1110764691","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110764691?lang=zh_cn&edition=full","pubTime":"2025-11-18 21:58","pubTimestamp":1763474337,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech发布2025年第三季度财务业绩，并强调在胰腺癌临床项目中的持续进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4557","AIM"],"gpt_icon":0},{"id":"1156910783","title":"AIM ImmunoTech公布关于Ampligen在治疗晚期复发性卵巢癌中协同潜力的临床试验新UPMC摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=1156910783","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156910783?lang=zh_cn&edition=full","pubTime":"2025-11-10 21:56","pubTimestamp":1762782981,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech公布关于Ampligen在治疗晚期复发性卵巢癌中协同潜力的临床试验新UPMC摘要","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","BK4139","AIM"],"gpt_icon":0},{"id":"2581205098","title":"Aim Immunotech Inc.盘中异动 急速上涨5.12%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581205098","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581205098?lang=zh_cn&edition=full","pubTime":"2025-11-06 00:52","pubTimestamp":1762361572,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日00时52分，Aim Immunotech Inc.股票出现波动，股价快速上涨5.12%。截至发稿，该股报1.68美元/股，成交量4.5481万股，换手率1.65%，振幅6.86%。Aim Immunotech Inc.股票所在的生物技术行业中，整体涨幅为1.06%。Aim Immunotech Inc.公司简介：AIM ImmunoTech Inc 是一家免疫制药公司，专注于研究和开发用于治疗多种癌症、病毒性疾病和免疫缺陷疾病的疗法，以及治疗目前疗法不足或未得到满足的癌症。Ampligen 已获准在阿根廷共和国进行商业销售，用于治疗严重的慢性疲劳综合症 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106005252a6e3b469&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106005252a6e3b469&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AIM","BK4139","BK4557"],"gpt_icon":0},{"id":"1131465187","title":"AIM ImmunoTech获得欧洲专利局授予的Ampligen®（Rintatolimod）用于治疗后新冠疲劳症状的专利","url":"https://stock-news.laohu8.com/highlight/detail?id=1131465187","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131465187?lang=zh_cn&edition=full","pubTime":"2025-11-03 21:55","pubTimestamp":1762178111,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech获得欧洲专利局授予的Ampligen®（Rintatolimod）用于治疗后新冠疲劳症状的专利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIM","BK4557","BK4139"],"gpt_icon":0},{"id":"2566426279","title":"业界首个企业应用AI成熟度模型（AIM²）在外滩大会发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2566426279","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566426279?lang=zh_cn&edition=full","pubTime":"2025-09-12 11:48","pubTimestamp":1757648880,"startTime":"0","endTime":"0","summary":"　　9月12日，在2025 Inclusion·外滩大会“洞见2035：AI驱动的产业突围与智能演进”见解论坛上，上海交通大学安泰经济与管理学院、中银科技金融学院联合中国太平洋保险集团、欧莱雅中国、乐刻运动、兴业银行和蚂蚁集团等多家领军企业，共同发布业界首个企业应用AI成熟度模型。AIM课题组负责人、上海交通大学安泰经济与管理学院副院长、中银科技金融学院执行院长刘少轩教授指出。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-09-12/doc-infqezvp7742705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AIM","BK4557","BK4139"],"gpt_icon":0},{"id":"2518522411","title":"Aim Immunotech Inc.盘中异动 快速拉升5.26%报0.140美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518522411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518522411?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:35","pubTimestamp":1741613723,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时35分，Aim Immunotech Inc.股票出现波动，股价大幅上涨5.26%。截至发稿，该股报0.140美元/股，成交量6.2388万股，换手率0.09%，振幅7.52%。Aim Immunotech Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Aim Immunotech Inc.公司简介：AIM ImmunoTech Inc是一家免疫制药公司，致力于研究和开发治疗免疫失调、病毒和癌症疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213523a26a262e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213523a26a262e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4557","AIM"],"gpt_icon":0},{"id":"2517944046","title":"Aim Immunotech Inc.盘中异动 急速上涨5.27%报0.130美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517944046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517944046?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:59","pubTimestamp":1741193960,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时59分，Aim Immunotech Inc.股票出现波动，股价快速上涨5.27%。截至发稿，该股报0.130美元/股，成交量33.1625万股，换手率0.48%，振幅9.97%。Aim Immunotech Inc.股票所在的生物技术行业中，整体涨幅为1.08%。Aim Immunotech Inc.公司简介：AIM ImmunoTech Inc是一家免疫制药公司，致力于研究和开发治疗免疫失调、病毒和癌症疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306005920989d674b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306005920989d674b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","AIM","BK4139"],"gpt_icon":0},{"id":"2516608703","title":"Aim Immunotech Inc.盘中异动 早盘大幅下挫5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516608703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516608703?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:14","pubTimestamp":1741101264,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时14分，Aim Immunotech Inc.股票出现异动，股价急速跳水5.91%。截至发稿，该股报0.113美元/股，成交量26.1457万股，换手率0.38%，振幅10.07%。Aim Immunotech Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Aim Immunotech Inc.公司简介：AIM ImmunoTech Inc是一家免疫制药公司，致力于研究和开发治疗免疫失调、病毒和癌症疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231424abe7fc8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231424abe7fc8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","AIM","BK4139"],"gpt_icon":0},{"id":"2516634735","title":"Aim Immunotech Inc.盘中异动 股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634735?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:32","pubTimestamp":1741012370,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时32分，Aim Immunotech Inc.股票出现异动，股价急速跳水5.63%。截至发稿，该股报0.127美元/股，成交量11.5122万股，换手率0.17%，振幅6.67%。Aim Immunotech Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Aim Immunotech Inc.公司简介：AIM ImmunoTech Inc是一家免疫制药公司，致力于研究和开发治疗免疫失调、病毒和癌症疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223250abe633a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223250abe633a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4557","AIM"],"gpt_icon":0},{"id":"2514373926","title":"Aim Immunotech Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514373926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514373926?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:08","pubTimestamp":1740755329,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时08分，Aim Immunotech Inc.股票出现异动，股价大幅下跌5.00%。截至发稿，该股报0.122美元/股，成交量9.5181万股，换手率0.14%，振幅2.97%。Aim Immunotech Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Aim Immunotech Inc.公司简介：AIM ImmunoTech Inc是一家免疫制药公司，致力于研究和开发治疗免疫失调、病毒和癌症疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282308499634226c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282308499634226c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4139","AIM"],"gpt_icon":0},{"id":"2514343389","title":"Aim Immunotech Inc.盘中异动 快速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514343389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514343389?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:57","pubTimestamp":1740668258,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时57分，Aim Immunotech Inc.股票出现波动，股价大幅下挫5.01%。截至发稿，该股报0.129美元/股，成交量13.2857万股，换手率0.19%，振幅5.74%。Aim Immunotech Inc.股票所在的生物技术行业中，整体涨幅为1.01%。Aim Immunotech Inc.公司简介：AIM ImmunoTech Inc是一家免疫制药公司，致力于研究和开发治疗免疫失调、病毒和癌症疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225738a256809f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225738a256809f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AIM","BK4557","BK4139"],"gpt_icon":0},{"id":"2514866150","title":"Aim Immunotech Inc.盘中异动 下午盘股价大涨6.46%报0.132美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514866150","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514866150?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:17","pubTimestamp":1740593830,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时17分，Aim Immunotech Inc.股票出现波动，股价快速上涨6.46%。截至发稿，该股报0.132美元/股，成交量24.8663万股，换手率0.36%，振幅13.24%。Aim Immunotech Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Aim Immunotech Inc.公司简介：AIM ImmunoTech Inc是一家免疫制药公司，致力于研究和开发治疗免疫失调、病毒和癌症疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270217109893d49e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270217109893d49e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AIM","BK4557","BK4139"],"gpt_icon":0},{"id":"2514777584","title":"Aim Immunotech Inc.盘中异动 早盘股价大跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514777584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514777584?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:00","pubTimestamp":1740412844,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时00分，Aim Immunotech Inc.股票出现波动，股价快速跳水5.50%。截至发稿，该股报0.131美元/股，成交量15.6261万股，换手率0.23%，振幅8.53%。Aim Immunotech Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Aim Immunotech Inc.公司简介：AIM ImmunoTech Inc是一家免疫制药公司，致力于研究和开发治疗免疫失调、病毒和癌症疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022500004498910a86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022500004498910a86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AIM","BK4139","BK4557"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aimimmuno.com","stockEarnings":[{"period":"1week","weight":-0.1356},{"period":"1month","weight":-0.2561},{"period":"3month","weight":-0.4023},{"period":"6month","weight":-0.6292},{"period":"1year","weight":-0.8738},{"period":"ytd","weight":-0.196}],"compareEarnings":[{"period":"1week","weight":-0.005},{"period":"1month","weight":-0.0136},{"period":"3month","weight":0.0038},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1725},{"period":"ytd","weight":0.006}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"AIM ImmunoTech Inc.是一个专业制药公司，其总部设在费城,宾夕法尼亚州，基于自然免疫系统增强技术从事临床开发新药物疗法用以治疗病毒性和基于免疫的慢性疾病。公司成立于20世纪70年代，致力于为美国国立卫生研究院做研究。自那时以来,该公司已经建立了一个强大的基础实验室、与自然干扰素和核酸相关的临床前和临床数据，用于提高人体的天然抗病毒防御系统，以及某些慢性病辅助治疗产品的开发。该公司国内有三个子公司——BioPro Corp 、BioAegean Corp、Core BioTech Corp，都是在特拉华州注册, 休眠状态。公司的外国子公司是emispherx Biopharma Europe N.V./S.A，1998年成立于比利时,其业务范围最小。在该公司巩固之后，所有重要子公司之间的结馀和交易都已被消除。","yearOnYearQuotes":[{"month":1,"riseRate":0.551724,"avgChangeRate":0.167884},{"month":2,"riseRate":0.344828,"avgChangeRate":0.019452},{"month":3,"riseRate":0.517241,"avgChangeRate":0.035765},{"month":4,"riseRate":0.448276,"avgChangeRate":0.020276},{"month":5,"riseRate":0.357143,"avgChangeRate":0.032622},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.001427},{"month":7,"riseRate":0.321429,"avgChangeRate":-0.024032},{"month":8,"riseRate":0.310345,"avgChangeRate":0.010354},{"month":9,"riseRate":0.37931,"avgChangeRate":-0.054048},{"month":10,"riseRate":0.37931,"avgChangeRate":0.04782},{"month":11,"riseRate":0.206897,"avgChangeRate":-0.091583},{"month":12,"riseRate":0.344828,"avgChangeRate":-0.100787}],"exchange":"AMEX","name":"AIM ImmunoTech Inc.","nameEN":"AIM ImmunoTech Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"AIM ImmunoTech Inc.(AIM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供AIM ImmunoTech Inc.(AIM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"AIM ImmunoTech Inc.,AIM,AIM ImmunoTech Inc.股票,AIM ImmunoTech Inc.股票老虎,AIM ImmunoTech Inc.股票老虎国际,AIM ImmunoTech Inc.行情,AIM ImmunoTech Inc.股票行情,AIM ImmunoTech Inc.股价,AIM ImmunoTech Inc.股市,AIM ImmunoTech Inc.股票价格,AIM ImmunoTech Inc.股票交易,AIM ImmunoTech Inc.股票购买,AIM ImmunoTech Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"AIM ImmunoTech Inc.(AIM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供AIM ImmunoTech Inc.(AIM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}